Literature DB >> 30116134

Benign transient hyperphosphatasemia in an infant during zinc supplementation.

Ayça Bilge Sönmez1, İlter Arifoğlu2, Ahmet Yıldırım1, Filiz Tütüncüler2.   

Abstract

Benign transient hyperphosphatasemia is characterized by a significant increase in alkaline phosphatase levels, which is detected incidentally in infancy and children without underlying bone and liver disease. This condition is a biochemical disorder rather than a clinical disorder and resolves within a short duration. Recognition of this entity by pediatricians is important to avoid unnecessary investigations. Here, we report an infant who was diagnosed as having benign transient hyperphosphatasemia based on clinical and laboratory findings who had increased alkaline phosphatase levels during zinc supplementation, with the aim of highlighting benign transient hyperphosphatasemia in infancy and childhood.

Entities:  

Keywords:  Alkaline phosphatase; benign transient hyperphosphatasemia; infant; zinc

Year:  2018        PMID: 30116134      PMCID: PMC6089789          DOI: 10.5152/TurkPediatriArs.2017.3158

Source DB:  PubMed          Journal:  Turk Pediatri Ars


  10 in total

1.  What is the cause of benign transient hyperphosphatasemia? A study of 35 cases.

Authors:  P M Crofton
Journal:  Clin Chem       Date:  1988-02       Impact factor: 8.327

Review 2.  Transient hyperphosphatasemia--where do we stand?

Authors:  S Kutílek; M Bayer
Journal:  Turk J Pediatr       Date:  1999 Apr-Jun       Impact factor: 0.552

3.  Effect of Zinc Supplementation on GH, IGF1, IGFBP3, OCN, and ALP in Non-Zinc-Deficient Children.

Authors:  Érika Dantas de Medeiros Rocha; Naira Josele Neves de Brito; Márcia Marília Gomes Dantas; Alfredo de Araújo Silva; Maria das Graças Almeida; José Brandão-Neto
Journal:  J Am Coll Nutr       Date:  2015-03-11       Impact factor: 3.169

4.  Benign transient hyperphosphatasemia in infants and children: a prospective cohort.

Authors:  Jonathan E Teitelbaum; Alexandra Laskowski; Frank P Barrows
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

Review 5.  Benign transient hyperphosphatasemia of infancy and childhood.

Authors:  N Tolaymat; M C de Melo
Journal:  South Med J       Date:  2000-12       Impact factor: 0.954

6.  Transient hyperphosphatasaemia: an important condition to recognize.

Authors:  A J Carroll; J C Coakley
Journal:  J Paediatr Child Health       Date:  2001-08       Impact factor: 1.954

7.  Transient benign hyperphophatasemia.

Authors:  Gianluca Gualco; Sebastiano A G Lava; Luca Garzoni; Giacomo D Simonetti; Alberto Bettinelli; Gregorio P Milani; Maria Cristina Provero; Mario G Bianchetti
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-08       Impact factor: 2.839

8.  Prevalence of transient hyperphosphatasemia among healthy infants and toddlers.

Authors:  Susanna Y Huh; Henry A Feldman; Joanne E Cox; Catherine M Gordon
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

9.  Viral infection of infants and children with benign transient hyperphosphatasemia.

Authors:  Mitsuyuki Suzuki; Toshio Okazaki; Tatsuo Nagai; Klara Törõ; Péter Sétonyi
Journal:  FEMS Immunol Med Microbiol       Date:  2002-07-12

10.  Transient hyperphosphatasemia in children revisited.

Authors:  Neta Dori; Lily Levi; Tamar Stam; Igor Sukhotnik; Ron Shaoul
Journal:  Pediatr Int       Date:  2010-12       Impact factor: 1.524

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.